
Oruka Therapeutics, Inc. (ORKA) earnings
- Healthcare
- NASDAQ
- Market cap$6.5B
Next report
2027-03-11
In 110 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -0.78
- -0.84 – -0.667 analysts
Latest result
12 days ago-5.1%EPS Miss
Estimate recorded after the release
2026-11-09Q3 FY2026
- EPS
- Reported / estimate-0.63 / -0.60
Stock reaction
Unavailable
Recent quarters
Latest 3 quarters| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-09 | -0.63 / -0.60 -5.1%¶ | — / — | Unavailable |
Q2 FY2026 2026-08-10 | -0.55 / -0.51 -7.3%¶ | — / — | +6.40% +6.43 pts vs SPY |
Q1 FY2026 2026-05-13 | -0.48 / -0.55 +12.2%¶ | — / — | Unavailable |
Reported / estimate
- Q3 FY2026 · 2026-11-09UnavailableEPS-0.63 / -0.60-5.1%¶Revenue— / —
- Q2 FY2026 · 2026-08-10+6.40%EPS-0.55 / -0.51-7.3%¶Revenue— / —
- Q1 FY2026 · 2026-05-13UnavailableEPS-0.48 / -0.55+12.2%¶Revenue— / —
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.